These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12652782)

  • 1. [Acquired coagulation abnormality due to factor V inhibitor].
    Iino N; Maruyama H; Gejyo F
    Nihon Naika Gakkai Zasshi; 2002 Nov; 91(11):3295-7. PubMed ID: 12652782
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
    Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
    Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with intravenous immunoglobulin (IVIg) in a patient with an acquired factor V inhibitor after liver transplantation.
    Guglielmone H; Jarchum G; Minoldo S
    Thromb Haemost; 2011 Nov; 106(5):985-6. PubMed ID: 21901236
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
    Borucki K; Töpfer G; Hartung KJ; Lutze G
    Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired factor V inhibitor treated with intravenous immunoglobulins].
    Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F
    Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation assay in a patient with acquired factor V inhibitor.
    Kindler S; Siegemund T; Führer D; Petros S
    J Thromb Haemost; 2008 Nov; 6(11):1985-7. PubMed ID: 18783483
    [No Abstract]   [Full Text] [Related]  

  • 7. The diversity in clinical presentation of acquired factor V inhibitor. Two case reports.
    Gadelha T; Aquino JH; Assunção e Silva E; Santos FL; de Oliveira MH
    Acta Haematol; 2008; 119(2):108-10. PubMed ID: 18367830
    [No Abstract]   [Full Text] [Related]  

  • 8. A case report of an acquired inhibitor to coagulation factor V.
    Shanmugam H; Jayaranee S; Eow GI
    Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete response of acquired FV inhibitor to rituximab.
    Ma ES; Liang RH; Chu KM; Lau GK
    Int J Hematol; 2015 Apr; 101(4):421-2. PubMed ID: 25616916
    [No Abstract]   [Full Text] [Related]  

  • 10. A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.
    Cadamuro J; Skocic M; Meisl B; Raggam RB; Felder TK; Prüller F; Reinstadler K; Wiedemann H; Mrazek C
    Clin Chem Lab Med; 2016 Jul; 54(7):e203-6. PubMed ID: 26677891
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor V inhibitor developing after liver transplantation in a 3-year-old child.
    Gordon B; Haire W; Duggan M; Langnas A; Shaw B
    Pediatrics; 1991 Jul; 88(1):156-9. PubMed ID: 2057253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Postoperative disorders of hemostasis caused by antifactor V circulating anticoagulant].
    Leclerc J; Charre S; Tournoys A; Gorski C; Goudemand J
    Ann Fr Anesth Reanim; 1995; 14(3):303-5. PubMed ID: 7486303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factor V inhibitor developed after the surgery of esophageal cancer].
    Okita M; Kunisaki C; Kurosawa N; Motizuki Y; Shinohara K; Negishi Y; Yamaguti S; Shimada H; Watanabe S
    Nihon Shokakibyo Gakkai Zasshi; 2000 Mar; 97(3):327-30. PubMed ID: 10741157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acquired inhibitor of factor V: an uncommon cause of prolonged coagulation tests].
    Hernández JA; Alonso A; Bermejo A; Velayos C
    Med Clin (Barc); 2006 Mar; 126(9):359. PubMed ID: 16650377
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation.
    Tessier-Marteau A; Croquefer S; Meziani F; Cau S; Asfar P; Macchi L
    Am J Hematol; 2010 Feb; 85(2):145-6. PubMed ID: 20052744
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of factor V inhibitor with complete correction of the PT and aPTT upon mixing.
    Lipshitz J; Chelliah T; Aledort L
    Am J Hematol; 2012 Mar; 87(3):313-5. PubMed ID: 22139582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired factor V inhibitor: etiology, bleeding risk and therapeutic management with regard to three cases].
    Schleinitz N; Veit V; Chouquet D; Seux V; Arnoux D; Mokart D; Lelong B; Alessi MC; Kaplanski G; Harlé JR
    Rev Med Interne; 2001 Nov; 22(11):1119-23. PubMed ID: 11817124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A circulating factor V inhibitor: possible side effect of treatment with streptomycin.
    Stenbjerg S; Husted S; Mygind K
    Scand J Haematol; 1975 May; 14(4):280-5. PubMed ID: 1153957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor V inhibitor after haematopoietic stem cell transplantation.
    Milojkovic D; Patel R; Ford E; Arya R; Mufti G
    Thromb Haemost; 2007 Sep; 98(3):685-7. PubMed ID: 17849062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.